Compound information
- Natural Products
- ZC3271560
- Molecular Formula
- C26H17ClFN3O3
- Molecular Weight
- 473.094247304 g/mol
- Structure
-
- IUPAC Name
- 5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-carbaldehyde
- InChI
- InChI=1S/C26H17ClFN3O3/c27-22-12-19(5-8-25(22)33-14-16-2-1-3-18(28)10-16)31-26-21-11-17(4-7-23(21)29-15-30-26)24-9-6-20(13-32)34-24/h1-13,15H,14H2,(H,29,30,31)
- InChI Key
- XQPZOUAAXRXPAM-UHFFFAOYSA-N
- SMILES
- O=Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
- Source
- ZINC000022054569
Warheads
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 5 |
Heteroatom Count | 8 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 77.25 Å2 | LogP | 5.812 |
LogS | -6.006 | LogD | 3.914 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.125 | Pgp substrate | 0.006 |
HIA | 0.965 | F20 % | 0.991 |
F30 % | 0.979 | Caco-2 | -5.136 |
MDCK | -4.958 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.258 | PPB | 98.346 |
VD | 1.643 | Fu | 1.977 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.981 | CYP1A2 substrate | 0.873 |
CYP2A6 substrate | 0.43 | CYP2B6 substrate | 0.725 |
CYP2C19 inhibitor | 0.624 | CYP2C19 substrate | 0.949 |
CYP2C8 substrate | 0.917 | CYP2C9 inhibitor | 0.738 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.094 |
CYP2D6 substrate | 0.819 | CYP2E1 substrate | 0.498 |
CYP3A4 inhibitor | 0.546 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.101 | CL | 6.52 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.468 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.058 | Rat Oral Acute Toxicity | 0.023 |
FDAMDD | 0.569 | Skin Sensitization | 0.002 |
Carcinogenicity | 0.404 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.884 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.818 | IGC50 | 5.695 |
LC50FM | -5.261 | LC50DM | 6.066 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.811 | NR-AR-LBD | 0.818 |
NR-AhR | 0.936 | NR-Aromatase | 0.817 |
NR-ER | 0.895 | NR-ER-LBD | 0.838 |
NR-PPAR-gamma | 0.968 | SR-ARE | 0.909 |
SR-ATAD5 | 0.924 | SR-HSE | 0.922 |
SR-MMP | 0.89 | SR-p53 | 0.962 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.